The Latest BenchSci News

news-header-image

Get assets for your articles

We've prepared logos and images of our product, team, and office for your use.

Download Media Kit

Find answers or schedule interviews

Read more about us, look through our help center, or reach out to chat.

Contact Us

Press Articles

best_places_inclusion
BenchSci Press Release
BenchSci named to 2023 Best Workplaces for Inclusion
BenchSci joins the list of Best Places for Inclusion chosen by Great Places to Work®. The recognition is based on the Trust Index score provided by employees.
BenchSci_News_Best_Workplace_MentalWellness_2023
BenchSci Press Release
BenchSci Named to 2023 Best Workplaces for Mental Wellness
BenchSci joins the list of Best Workplaces for Mental wellness, chosen by Great Place to Work®. The recognition is based on the Trust Index score provided by employees.
BenchSci named to 2023 Best Workplaces in Ontario
BenchSci Press Release
BenchSci named to 2023 Best Workplaces in Ontario
BenchSci joins the list of Best Workplaces in Ontario chosen by Great Places to Work®. The recognition is based on the Trust Index score provided by employees.
BenchSci_News_Best_Places_To_Work_2023
BenchSci Press Release
BenchSci named to 2023 Best Workplaces for Professional Development
BenchSci joins the list of Best Places for Professional Development chosen by Great Places to Work®. The recognition is based on the Trust Index score provided by employees.
BenchSci_SeriesD_NewsThumb
BenchSci Press Release
BenchSci Raises $95 Million Series D Funding to Enable Drug Discovery Innovation at Scale With its Groundbreaking AI Platform ASCEND
$95 million (US $70 million) Series D funding round led by Generation Investment Management
UK_Talent_Survey_News-March-2023
BenchSci Press Release
Tech employees prioritize long-term business growth, amid ongoing market instability
New research from Artificial Intelligence (AI) scale-up BenchSci highlights the need for companies to help employees maximize ‘the business of me’, as tech talent seeks stability and progression in uncertain times
Best_Places_To_Work_2023
Best Workplaces™ for Women 2023
BenchSci named to 2023 Best Workplaces for Women
BenchSci joins the ranks of 100 Canadian organizations chosen by Great Place to Work® based on the average Trust Index score provided by the women that work there.
BenchShi News_Article Post_900x600-1
BenchSci Press Release
BenchSci Announces Launch of ASCEND™ – a First-of-its-Kind ‘Map’ of All Disease Biology that Aims to Transform Pharmaceutical Research
The SaaS solution is powered by proprietary machine-learning technology that reads and interprets data like a PhD scientist
TheVectorAI20_900x600
Vector Institute
BenchSci named to Vector AI20 for 2023
BenchSci was chosen for the Vector Institute's inaugural Vector AI20 for 2023 list out of 150+ Canadian AI start-ups for transforming the drug discovery process
Delloite50and500_News_Preview_900x600
BenchSci Press Release
BenchSci Ranked Among Fastest-Growing Tech Companies in North America by Deloitte
Attributes over 800% revenue growth to proprietary machine learning technology, entrepreneurial spirit, and world-class remote team
News_Data Release Mary Ann Liebert_October2022
BenchSci Press Release
BenchSci Launches New Data from Over 100 Biomedical Journals onto Platform
Through an agreement with Mary Ann Liebert Inc. publishers, BenchSci’s users will now have additional access to critical experimental insights from over 38,000 additional articles
LI_topStartups_september2022
BenchSci Press Release
BenchSci Ranked 6th on LinkedIn's 2022 Top Startups
BenchSci made the 5th annual LinkedIn Top Startups list in Canada. We ranked 6th out of 15 of the best startups based on the employment growth, engagement, job interest and attraction of top talent we saw this year.
CB_Insights_News_Preview
CB Insights Advanced Manufacturing 50
BenchSci Named to the 2022 CB Insights’ Advanced Manufacturing 50 List
BenchSci was selected out of 6,000 companies as one of the best R&D optimization tools for the first annual Advanced Manufacturing 50 list from CB Insights
Copy of Collision booth
BenchSci Press Release
BenchSci Announces Total Funding of $27.2 Million as Gradient Ventures Increases Investment, Helping to Meet Demand for Toronto Company’s AI Drug Discovery Technology
Will expand Toronto office and team, and global salesforce.
collision-sign-2022
UofT News
Toronto hosts Collision tech conference amid growing global acclaim for U of T startups
BenchSci CEO Liran Belenzon will speak at Collision 2022 about the importance of investing in culture early especially at hypergrowth companies
Ask-AI-900x600
Ask AI Podcast
How is AI accelerating the science behind pharmaceutical research?
Liran Belenzon joins the Ask AI podcast to talk about how BenchSci is helping bench scientists make breakthroughs faster
EY-News-May 2022
EY Entrepreneur Of The Year ® 2022
Liran Belenzon named EY Entrepreneur Of The Year ® 2022 Ontario finalist
This is the second year in a row that Liran Belenzon, CEO of BenchSci, has made the list for his vision of success beyond success and making ESG practices an integral part of company culture
Best-Workplaces-in-Canada-News_May 2022
Best Workplaces™ in Canada 2022
BenchSci ranks 10th on Best Workplaces™ in Canada
BenchSci is among the top 10 Best Workplaces in Canada for 100-999 employees and makes the list of Best Workplaces for Start-Ups 2022
jeanMichelLemieux_pressRelease_900x600
BenchSci Press Release
Technology Leader and Former Shopify Executive Jean-Michel Lemieux Joins BenchSci Advisory Board
Experience scaling technology companies will help guide expansion of drug R&D acceleration platform to additional applications and customers
jessica_neal
BenchSci Press Release
Netflix Culture Builder Jessica Neal Joins BenchSci Advisory Board
HR veteran will work with biomedical SaaS scale-up to create an unsurpassed employee experience
option1_seriesC_newsImage_January2022
BenchSci Press Release
BenchSci Raises $63 Million Series C to Solve Pharma's Biggest R&D Challenges with AI-Powered Software Platform
Led by Inovia Capital and TCV, funding brings total investment to $123 million and will expedite expansion of machine learning technology used in 16 of the top 20 pharmaceutical companies
NewsImage-2_OUP Announcement_SocialMedia_Jan2022
BenchSci Press Release
BenchSci Agreement with Oxford University Press Gives Access to Critical Experimental Insights from over 120 Bioscience Journals
Data from top journals at world’s largest university publisher will enhance BenchSci’s biomedical database, helping scientists accelerate R&D for novel medicine development
deloitte_news_Nov2021
BenchSci Press Release
BenchSci Named a Deloitte Technology Fast 50™ Company as Impact on Drug Discovery Grows
Program recognizes the country’s 50 most innovative and fastest-growing technology companies, reflected in BenchSci's expanding products and commercial success
PCR_Press_Release_Featured
BenchSci Press Release
BenchSci Accelerates Gene Function Research with Addition of PCR Products and Sequences
Crucial molecular biology technique enables scientists to better understand how genes influence health and disease
dennisKavelman_news_page
BenchSci Press Release
Inovia Capital Partner and Former RIM CFO and COO Dennis Kavelman Joins BenchSci Board of Directors
Experienced technology executive brings operational expansion expertise to hypergrowth biomedical machine learning startup
remote_first_news
BenchSci Press Release
Office is Optional for BenchSci Employees as Hypergrowth Machine Learning Startup Embraces Being Remote-first
Building on success working remotely during the pandemic, BenchSci adapts to the changing nature of work with location freedom, new collaboration space, and experiments with emerging technology such as virtual reality
Bonita_news
BenchSci Press Release
Google Veteran Bonita Stewart Joins BenchSci Board of Directors
Gradient Ventures board partner will provide a unique perspective on technology from a four-decade career driving business transformation
Vanessa_Ribreau_News
BenchSci Press Release
Vanessa Ribreau Joins BenchSci as Chief People Officer to Lead Company's Embrace of the Future of Work
In the face of unprecedented workplace changes, senior HR leader will continue the evolution of BenchSci's progressive and award-winning culture
craig_news_page
BenchSci Press Release
BenchSci Announces Craig Newell as New Chief Architect Officer as it Broadens Biomedical AI Platform
Following the company's expansion to AI-assisted animal model selection, the appointment reflects the complexity of applying machine learning to biology and recognizes Newell’s product architecture expertise
Globe_Mail_News
The Globe and Mail
Canadian Companies Emerge from COVID-19 Pandemic with New Diversity and Inclusion Plans
It’s not hard to understand why, more than a year after Black Lives Matter protests, Canadian firms are spearheading new ways to support diversity and inclusivity in the workplace.
Animal_Model_Press_Release
BenchSci Press Release
BenchSci Extends Impact on Drug Discovery with Addition of AI-Assisted Animal Model Selection
Addition of new product type to the BenchSci platform empowers scientists with relevant experimental evidence to accelerate novel medicine to clinical trials
Luba-G_full
BenchSci Press Release
BenchSci Expands Board of Directors with Appointment of Life Sciences, Tech, and Healthcare Leader Luba Greenwood
Industry veteran will provide strategic guidance to company as it pursues its vision of using machine learning to bring novel medicine to patients 50% faster by 2025
Eran_Headshot
BenchSci Press Release
BenchSci Signifies Growth of Machine Learning Product Portfolio with Appointment of Chief Platform Officer
Experienced product and engineering leader Eran Ben-Ari joins BenchSci to scale the creation of a sophisticated machine learning-based product portfolio that's transforming life-saving R&D
advisors_news
BenchSci Press Release
Three Senior Pharma R&D Leaders Join BenchSci's Science Advisory Board
Steve Hitchcock, Philip Larsen, and Philip Tagari named science advisors, providing BenchSci with global industry expertise to realize its vision of using machine learning to bring novel medicine to patients 50% faster by 2025
BestWorkplaces-News
BenchSci Press Release
BenchSci Ranks 26 on the 2021 List of 50 Best Workplaces in Canada
Certification reflects focus on building a strong culture and supporting mental wellness, diversity, equity, and inclusion
bullfrog_partnership_blogheader_news
BenchSci Press Release
BenchSci Becomes Country's First Company to Offset Remote Work Emissions
With partner Less Emissions, BenchSci launched a unique program as part of our climate-positive business initiative.
BWFS_2021_resized
BenchSci Press Release
BenchSci Listed as Best Workplace™ for Startups in Canada for Second Consecutive Year
The recognition reflects vision to bring medicine to patients 50% faster by 2025, and reaffirms dedication to employee wellbeing.
googlecloud-article
Google Cloud Blog
BenchSci Helps Pharma Deliver New Medicines—Stat!—with Google Cloud
See how BenchSci uses Google Cloud to grow our business and pursue our mission to accelerate life-saving biomedical research.
Taylor_Francis_Announcement (1)
BenchSci Press Release
BenchSci Expands Scientists' Access to Critical Experimental Insights With Addition of Top Journals From Taylor & Francis
The agreement will enhance BenchSci's vast biomedical database to help scientists run more successful experiments while increasing the discoverability of Taylor & Francis Group research.
R2005L_GREENWOOD-1
Harvard Business Review
How to Win with Machine Learning
BenchSci is featured in this Harvard Business Review article discussing companies using machine learning to transform products and industries and create more value.
BestPlaceToWork_Blog_May2020V1
BenchSci Press Release
BenchSci Certified as Great Place to Work® and Listed as Best Startup Workplace
The certification reflects mission to exponentially increase the speed and quality of life-saving research, and focus on employee health and wellness.
COVID-19_blog_march19
BenchSci Press Release
AI-Derived COVID-19 Experimental Data and Reagent Insights Now Available from BenchSci
Open-access data will help scientists select antibody, RNAi, and protein reagents to expedite the development of treatments and vaccines.
BenchSciGoogleDesign-4
Google Design
BenchSci Profiled by Google Design as a Top Example of AI User Experience
Google Design Centered host Di Dang meets with BenchSci, a startup using AI to help biomedical researchers discover new drug treatments.
BS_Founders_A_1200x800
Endpoints News
F-Prime Backs a Niche AI Software Startup Hunting Lofty Goals in $22m Series B
For many of the AI companies sprouting on the biopharma field, validation — often meaning confirmation of whether the targets and drugs they identified or generated would actually work — won’t come in years, if at all. But for BenchSci, the drug hunting field is their home turf.
H63UXQL5MZH5FB5OEBJJ7VEPDE
The Globe and Mail
BenchSci Raises Financing to Expand Artificial Intelligence Search Capability for Scientists
Toronto startup BenchSci, which uses AI to help biomedical scientists cut time and costs from research, is extending its reach with a US$22-million fundraising round led by a Fidelity Investments Inc.-linked venture firm.
Figures Result-BenchSci
VentureBeat
Benchsci Raises $22 Million for AI-Powered Drug Discovery Tools
Assessing the health of pharmaceutical R&D by unearthing hidden patterns in procurement data is a task made simpler by AI.
benchsci
Betakit
BenchSci Raises $29 Million CAD Series B Round
BenchSci has raised a $29 million CAD ($22 million USD) Series B funding round led by F-Prime Capital.
Untitled-design
BenchSci Press Release
BenchSci Raises $22 Million Series B and Launches New AI-Assisted Reagent Selection Product to Optimize $10.2 Billion in Life Science R&D Spend
F-Prime Capital led the round with participation from existing investors including Gradient Ventures, Google’s AI fund.
BenchSci-group-weblead
U of T News
With Google's Backing, U of T Startup BenchSci Uses AI to Create "Super Scientists"
In less than three years, biomedical firm BenchSci has gone from four people sitting around a table to a 50-strong operation backed by Google.
BenchSci Announces Total Funding of $27.2 Million as Gradient Ventures Increases Investment, Helping to Meet Demand for Toronto Company’s AI Drug Discovery Technology
BenchSci Press Release
BenchSci Announces Total Funding of $27.2 Million as Gradient Ventures Increases Investment, Helping to Meet Demand for Toronto Company’s AI Drug Discovery Technology
Will expand Toronto office and team, and global salesforce.
Sanbio_BV_logo
Sanbio B.V.
Sanbio B.V. Partners with BenchSci to Augment Visibility and Purchasability of Its IHC Antibodies
Partnership will leverage BenchSci’s AI to help scientists find MONOSAN® antibodies for running successful IHC experiments.
abclonal-logo-rectangle-on-white-01
ABclonal
ABclonal Technology Partners with BenchSci to Boost Discoverability of its Novel Products
Partnership will leverage BenchSci’s AI to help scientists find the right reagents and enable ABclonal to compete on product quality.
Milind_Kamkolkar
BenchSci Press Release
Biotech Chief Data Officer Milind Kamkolkar Joins Advisory Board of AI-Powered Life Science R&D Accelerator BenchSci
Appointment reinforces Google AI fund-backed company's leadership in using machine learning to drive faster, more cost-effective, and higher impact biomedical discoveries.
Active Motif
Active Motif
Active Motif Partners with BenchSci to Increase Discoverability of Epigenetics-related Products
Partnership will leverage BenchSci’s artificial intelligence to help researchers find the right antibodies faster than ever before.
ankit_jain-2
BenchSci Press Release
Gradient Ventures Founding Partner Ankit Jain Joins Board of Biomedical AI Startup BenchSci
Appointment made as BenchSci announces a more than 5x increase in biomedical experiments understood by its machine learning technology.
Proteintech logo
Proteintech
Proteintech Partners With BenchSci to Boost Researchers' Antibody Data Searches
Partnership will accelerate science with "rocket fuel" that lets researchers make better decisions faster than ever before.
genetex-logo
GeneTex
GeneTex Partners With BenchSci to Augment Antibody Catalog Publication Data
Partnership will use BenchSci's artificial intelligence to help researchers run successful experiments with the right antibody.
Bio-Techne PR
Bio-Techne
Bio-Techne Partners with BenchSci to Enhance Available Publication Data of Its Commercial Antibodies
Novus Biologicals and R&D Systems will list their catalog of antibodies on BenchSci to increase the amount of published antibody validation data available to researchers.
IMG_8114-5
BenchSci Press Release
Accomplished Life Science Entrepreneur Karen Padgett Joins BenchSci Advisory Board
Karen's experience will ensure we solve our suppliers' most pressing problems with purpose-built solutions.
press-20
Thermo Fisher Scientific
Thermo Fisher Scientific to Provide Antibody Publication Data on its Website
Researchers can view published data on antibodies directly on the website to help better understand antibody performance.
press-19
BenchSci Press Release
BenchSci Ranked One of the Top 25 Up and Coming Technology Companies on the Branham300
Recognition follows news of BenchSci becoming the first non-US company to receive investment from Gradient Ventures, Google’s AI-focused venture fund.
press-18
BenchSci Press Release
Lab Launch Inc. Partners with BenchSci to Provide Startups Time-Saving Research Tools
BenchSci, an AI-driven platform that decodes published figures to help scientists find antibody usage data, is partnering with Lab Launch Inc., a nonprofit biotechnology incubator supporting startups in the Los Angeles area.
press-17
The Company of Biologists
The Path to VICTORy – a Beginner's Guide to Success Using Commercial Research Antibodies
Author Simon L. Goodman cites BenchSci as a tool that can help address issues with antibodies that contribute to the reproducibility crisis.
press-16
Karger
Karger Publishers Partners with BenchSci to Help Scientists Find the Right Products for Their Experiments
Researchers can find biological product data faster on BenchSci’s platform, saving time and helping increase the speed of scientific discovery.
press-15
CBC
Canada's BenchSci Gets Cash Infusion from Google Parent Alphabet
"Tom Leung, co-founder and chief scientist of BenchSci, talks about Google’s parent, Alphabet, investing millions in the Toronto biomedical startup, which uses AI to help scientists sift through research papers for scientific discoveries and product reviews."
press-14
The Globe and Mail
Alphabet's AI Venture Capital Firm Makes First Investment in Canada with BenchSci
"Alphabet Inc.’s nascent artificial-intelligence venture fund has picked its first Canadian investment: BenchSci, a Toronto biomedical startup that uses machine learning to scan millions of data points in biomedical research papers, generating searchable results to help shorten the drug discovery process."
press-13
BenchSci Press Release
BenchSci Raises US$8 Million Series A to Accelerate Biomedical Discoveries with AI-Powered Search Engine for Biological Products
Latest round of funding from iNovia Capital, Gradient Ventures, and others positions BenchSci to execute on its mission, and take its place in the market as one of the world’s top machine learning companies.
press-12
Science: Disrupt
Responsible Science
BenchSci CSO Tom Leung contributes to a discussion on startups making science more responsible through new technologies and tools.
press-11
BenchSci Press Release
Wiley Partners with BenchSci to Give Scientists Unprecedented Insight into Biological Products
John Wiley and Sons Inc. today announced that it has partnered with BenchSci, a life science machine learning software startup, that aims to improve the speed and effectiveness of selecting biological products for experiments.
press-10
Springer Nature
Biomedical Researchers to Benefit from New Partnership Between Springer Nature and BenchSci
Springer Nature has partnered with BenchSci, making data from over 200 of the world's top journals available to assist scientists in finding biological products for experiments.
press-9
LabWorm
Top 17 Research Tools of 2017
BenchSci made LabWorm's top 17 trending research tools of 2017 that were most appreciated and used by the LabWorm community.
press-8
Forbes
In the Lab of the Future, Robots Run Experiments While Scientists Sleep
"When it comes to experimental design, companies like BenchSci use artificial intelligence to streamline the process, in this case by finding antibodies to target proteins of interest."
press-7
BetaKit
BenchSci’s David Chen: Startup CTOs Need to Be Ready for ‘Unknown Unknowns’
Our CTO, David Chen, was featured in startup news publication BetaKit about using machine learning to help medical researchers solve complex medical challenges.
press-6
UHN Research
Game Changer: Benchsci
"BenchSci’s platform will effectively standardize experimental protocols, increase researchers’ productivity, and prevent usage of inappropriate antibodies that lead to erroneous results."
press-5
MilliporeSigma
MilliporeSigma Hosts Leading Scientists at Life Science Symposium in Greater Boston
BenchSci CEO and co-founder Liran Belenzon joined world-renowned academic researchers, technology experts, and industry entrepreneurs to speak about advances and opportunities in life science.
press-2-banner
BenchSci Press Release
BenchSci Partners with The FASEB Journal to Increase Discoverability of Content
BenchSci will now include FASEB’s flagship publication, The FASEB Journal (FJ), on its platform to increase discoverability of relevant scientific compounds discussed within The FASEB Journal-published articles.
press-3
Laboratory News
The Great Reproducibility Problem
"Using filters for specific experimental contexts, BenchSci can help scientists quickly and easily identify the most relevant published figures and associated antibodies within seconds, ensuring that scientists can make an evidence-based decision on antibody selection."
press-4
BenchSci Press Release
ASPET Partners with BenchSci to Increase Discoverability of Its Journals
BenchSci will now include four ASPET journals on its platform to increase discoverability of relevant scientific compounds discussed within ASPET-published articles.
press-1
Globe and Mail
Science Startups Make Research Faster, Cheaper, More Accurate
"BenchSci has taught a computer to read scientific papers and identify the specific antibodies used as well as other variables, such as specific techniques, tissues and disease used in the experiment."
BestWorkplaces-News
BenchSci Press Release
BenchSci Ranks 26 on the 2021 List of 50 Best Workplaces in Canada
Certification reflects focus on building a strong culture and supporting mental wellness, diversity, equity, and inclusion